Provisional Grant of Options

RNS Number : 8495V

Allergy Therapeutics PLC

17 July 2009

 



Allergy Therapeutics PLC - News Announcement - Allergy Therapeutics - Grant of Options

Allergy Therapeutics PLC

17 July 2009

Provisional Grant of Options

Allergy Therapeutics plc ('the Company') announces that, pursuant to the Allergy Therapeutics plc Long Term Share Incentive Plan ('LTIP'), on 16 July 2009 provisional shares of 0.1 pence each in the share capital of the Company were awarded to the following directors, Manuel Llobet (Executive Director), Ian Postlethwaite (Finance Director), Christian Gratz (Executive Director) and Tom Holdich (Executive Director) at nil cost, as follows:

Director	Number of provisional shares awarded	Date of distribution	Total provisional shares held under LTIPs
Manuel Llobet	750,000	16 July 2012	750,000
Ian Postlethwaite	600,000	16 July 2012	864,691
Christian Gratz	600,000	16 July 2012	893,320
Tom Holdich	600,000	16 July 2012	871,805

The distribution of these ordinary shares of 0.1 pence each under the LTIP is conditional on the Company's performance over the course of the next three years.

For further information

Allergy Therapeutics     Keith Carter, Chief Executive www.allergytherapeutics.com	[phone]
Nomura Code Securities             Juliet Thompson/ Clare Terlouw	[phone]

 

END

 

 

RDSGUUWCMUPBUMM